Short answer · Medically reviewed summary · Last updated: 2026-04-07
Phenylketonuria (PKU) is a strictly hereditary, autosomal recessive genetic disorder caused by mutations in the PAH gene that prevent the body from properly breaking down the amino acid phenylalanine. Because it is inherited through a recessive pattern, both parents must typically be carriers for a child to be born with the condition, and it is not caused by spontaneous or de novo mutations. Is Phenylketonuria hereditary? Yes, Phenylketonuria is a classic example of an inherited metabolic disorder.
2 people with Phenylketonuria have shared their first-person experience on this question at DiseaseMaps.
Phenylketonuria (PKU) is a strictly hereditary, autosomal recessive genetic disorder caused by mutations in the PAH gene that prevent the body from properly breaking down the amino acid phenylalanine. Because it is inherited through a recessive pattern, both parents must typically be carriers for a child to be born with the condition, and it is not caused by spontaneous or de novo mutations.
Yes, Phenylketonuria is a classic example of an inherited metabolic disorder. It is strictly genetic, meaning it is passed down through families via DNA. It is not caused by environmental factors or lifestyle choices. In medical terms, we classify Phenylketonuria as an autosomal recessive condition. This means that for an individual to manifest the disease, they must inherit two copies of the mutated PAH gene—one from each biological parent. Because parents who are carriers (having only one mutated copy) are typically asymptomatic, the condition can often appear unexpectedly in families with no prior history of the disease.
When both parents are carriers of a PAH gene mutation, the mathematical probability for each pregnancy is as follows:
If one parent has Phenylketonuria and the other is not a carrier, all children will be carriers, but none will have the disease. If one parent has Phenylketonuria and the other is a carrier, there is a 50% chance for each pregnancy that the child will have the condition.
Genetic testing is a vital tool for families affected by Phenylketonuria. While newborn screening (the "heel prick" test) identifies the condition shortly after birth by measuring phenylalanine levels in the blood, molecular genetic testing is used to identify the specific mutations within the PAH gene. This is highly recommended to confirm the diagnosis and can help clinicians predict the severity of the phenotype and potential response to specific therapies, such as sapropterin dihydrochloride.
Genetic counseling is strongly recommended for individuals with Phenylketonuria who are planning a pregnancy, as well as for their partners. A genetic counselor can help families understand their specific recurrence risks and discuss reproductive options, such as carrier testing for partners or prenatal diagnostic procedures like chorionic villus sampling (CVS) or amniocentesis. For women with Phenylketonuria, strict metabolic control before and during pregnancy is essential to prevent maternal PKU syndrome, which can impact fetal development.
Medical disclaimer: This information is for educational purposes only and does not substitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.